Summary Information:
Agios Pharmaceuticals Inc. Common Stock
NASDAQ:AGIO


email
[email protected]
Our Main Pages
Stocks.TRoach.Net
TRoach.Org
TRoach.Net

NOTE: This page is for evaluation of a JFF Project.
This page is NOT updated on a regular basis.
Information on this page should NOT be used for investment purposes.


Agios Pharmaceuticals Inc. Common Stock
Exchange: NASDAQ
Symbol: AGIO
SEC CIK: 0001439222
Phone: 617-649-8600
88 SIDNEY STREET
CAMBRIDGE MA 02139

CEO: Jacqualyn Fouse
Price when page updated: 22.65 Date: 2023-11-30
Company Website:
www.agios.com

_Description: Agios is focused on discovering and developing novel investigational medicines to treat malignant hematology, solid tumors and rare genetic diseases through scientific leadership in the field of cellular metabolism. In addition to an active research and discovery pipeline across these three therapeutic areas, Agios has two approved oncology precision medicines and multiple first-in-class investigational therapies in clinical and/or preclinical development.

IPO YEAR:
2013
Sector:
Health Care
Industry:
Biotechnology: Pharmaceutical Preparations
ADRTSO:

MarketCap:
1265937583.00
Beta:
0.695077895165635
52 Week High:
62.16
52 Week Low:
29.21
52 Week Change:
-0.20642303433001108
Short Interest:

Short Date:

Shares Outstanding:
54308474
Dividend Rate:
0
Dividend Yield:
N/A
ExDividend Date:

Latest EPS:

Latest EPS Date:
2 Nov 2022
Float:
0
return on Equity:
-29.50%
Consensus EPS:

Number Of Estimates:

EPS Surprise Dollar:

Eps Surprise Percent:

EBITDA:
-$356.31
ttmEPS:
24.93
Revenue:
$6.414M
Gross Profit:

Cash:

Debt:

Institution Percent:
-
Revenue Percent:

Revenue Per Employee:

Insider Percent:
0.30%
Return on Assets:
-26.60%
Return on Capital:

Profit Margin:
-
Price to Sales:
251.34
Price To Book:
1.40
Short Ratio:
7.66
PE Ratio:
1.2148909575977798
Employees:
562
1Y Guesstimate
37.761:1.0:6




__The following are links to various summary and news pages for
__Agios Pharmaceuticals Inc. Common Stock [ AGIO ].

__Note: Some Links might not have information for the company.


finance.Yahoo.com money.CNN.com NASDAQ research
WalletInvestor.com WSJ.com MarketBeat.com
finviz.com WallMine.com TheGlobeandMail.com
stock1010.com
NASDAQ - General Info SEC Insider Report Ownership Summary
Dividend History insiderbuyingselling.com
Facebook search Twitter search LinkedIn search
PRnewsWire.Com Google Forecast
tdameritrade.com BarChart.com
SeekingAlpha.com Markets.FT.com stocktwits.com
FinTel.io Ldmicro.com bloomberg.com
MarketWatch.com Reuters.com businessinsider.com
fool.com barrons.com zacks.com
GuruFocus.com Investing.com tipranks.com
thestreet.com nytimes.com earningswhispers.com
marketchameleon.com sunshineavenue.com stockinvest.us
stockanalysis.com stockconsultant.com ycharts.com
financialcontent.com docoh.com foxbusiness.com
cnbc.com investorsobserver.com tradingview.com
investopedia.com tmxmoney.com invest.cnyes.com
ask.com bing.com brave.com
duckduckgo.com ecosia.org excite.com
exalead.com gibiru.com hotbot.com
www.info.com infospace.com lycos.com
lukol.com metacrawler.com mojeek.com
becovi.com searx.thegpm.org search.com
swisscows.com webcrawler.com yahoo.com
yandex.com yep.com you.com




INDEX




Page design by: TRoach
Page Last Updated: 2023-11-30